585 related articles for article (PubMed ID: 33812037)
1. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
[TBL] [Abstract][Full Text] [Related]
2. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
[TBL] [Abstract][Full Text] [Related]
3. Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication.
Vaddadi K; Gandikota C; Huang C; Liang Y; Liu L
Am J Physiol Cell Physiol; 2023 Aug; 325(2):C420-C428. PubMed ID: 37399496
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection.
Lodhi N; Singh R; Rajput SP; Saquib Q
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445373
[TBL] [Abstract][Full Text] [Related]
5. Why are some coronavirus variants more infectious?
Mukherjee R; Satardekar R
J Biosci; 2021; 46(4):. PubMed ID: 34785628
[TBL] [Abstract][Full Text] [Related]
6. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
Klaassen K; Stankovic B; Zukic B; Kotur N; Gasic V; Pavlovic S; Stojiljkovic M
Infect Genet Evol; 2020 Oct; 84():104498. PubMed ID: 32771700
[TBL] [Abstract][Full Text] [Related]
7. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™.
Kumar N; Golhar R; Sharma KS; Holloway JL; Sarangi S; Neuhaus I; Walsh AM; Pitluk ZW
BMC Genomics; 2021 Jan; 22(1):5. PubMed ID: 33407110
[TBL] [Abstract][Full Text] [Related]
8. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
Kim WR; Park EG; Kang KW; Lee SM; Kim B; Kim HS
Mol Cells; 2020 Nov; 43(11):953-963. PubMed ID: 33199671
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Variants and Vaccine Development.
Zhao Z; Bashiri S; Ziora ZM; Toth I; Skwarczynski M
Viruses; 2024 May; 16(5):. PubMed ID: 38793638
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic factors associated with increased severity of Covid-19.
Yildirim Z; Sahin OS; Yazar S; Bozok Cetintas V
Cell Biol Int; 2021 Jun; 45(6):1158-1174. PubMed ID: 33590936
[TBL] [Abstract][Full Text] [Related]
11. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms.
Ahmadian E; Hosseiniyan Khatibi SM; Razi Soofiyani S; Abediazar S; Shoja MM; Ardalan M; Zununi Vahed S
Rev Med Virol; 2021 May; 31(3):e2176. PubMed ID: 33022818
[TBL] [Abstract][Full Text] [Related]
12. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19
Bertolazzi G; Cipollina C; Benos PV; Tumminello M; Coronnello C
Front Cell Infect Microbiol; 2020; 10():586592. PubMed ID: 33194826
[TBL] [Abstract][Full Text] [Related]
13. Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges.
Jia H; Neptune E; Cui H
Am J Respir Cell Mol Biol; 2021 Apr; 64(4):416-425. PubMed ID: 33296619
[TBL] [Abstract][Full Text] [Related]
14. Clinically informative microRNAs for SARS-CoV-2 infection.
Ergün S; Sankaranarayanan R; Petrović N
Epigenomics; 2023 Jul; 15(13):705-716. PubMed ID: 37661862
[TBL] [Abstract][Full Text] [Related]
15. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
Chan AP; Choi Y; Schork NJ
mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
Cai G; Du M; Bossé Y; Albrecht H; Qin F; Luo X; Androulakis XM; Cheng C; Nagarkatti M; Nagarkatti P; Christiani DC; Whitfield ML; Amos CI; Xiao F
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502134
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs.
Rasizadeh R; Aghbash PS; Nahand JS; Entezari-Maleki T; Baghi HB
Virol J; 2023 Aug; 20(1):179. PubMed ID: 37559103
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review).
Shang J; Du L; Han N; Lv D; Wang J; Yang H; Bai L; Tang H
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576464
[TBL] [Abstract][Full Text] [Related]
19. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.
Samad A; Jafar T; Rafi JH
Genomics; 2020 Nov; 112(6):4912-4923. PubMed ID: 32916258
[TBL] [Abstract][Full Text] [Related]
20.
Baig MS; Deepanshu ; Prakash P; Alam P; Krishnan A
J Biomol Struct Dyn; 2023; 41(21):12305-12327. PubMed ID: 36752331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
